Adrenocortical Carcinoma-Reference-Cited by-同舟云学术

Adrenocortical Carcinoma

Published:2013-12-20 Issue:2 Volume:35 Page:282-326
ISSN:0163-769X
Container-title:Endocrine Reviews
language:en
Short-container-title:

Author:

Else Tobias¹,Kim Alex C.²,Sabolch Aaron³,Raymond Victoria M.¹,Kandathil Asha³²,Caoili Elaine M.³²,Jolly Shruti³,Miller Barbra S.²,Giordano Thomas J.¹³²,Hammer Gary D.¹

Affiliation:

1. MEND/Division of Metabolism, Endocrinology, and Diabetes (T.E., T.J.G., G.D.H.), Division of Molecular Medicine and Genetics (V.M.R.), Department of Internal Medicine; University of Michigan Hospital and Health Systems, Ann Arbor, Michigan 48109

2. Division of Endocrine Surgery (B.S.M.), Section of General Surgery, (A.C.K.), Department of Surgery, University of Michigan Hospital and Health Systems, Ann Arbor, Michigan 48109

3. Departments of Radiation Oncology (A.S., J.S.), Pathology (T.J.G.), and Radiology (A.K., E.M.C.); University of Michigan Hospital and Health Systems, Ann Arbor, Michigan 48109

Abstract

Abstract Adrenocortical carcinoma (ACC) is a rare endocrine malignancy, often with an unfavorable prognosis. Here we summarize the knowledge about diagnosis, epidemiology, pathophysiology, and therapy of ACC. Over recent years, multidisciplinary clinics have formed and the first international treatment trials have been conducted. This review focuses on evidence gained from recent basic science and clinical research and provides perspectives from the experience of a large multidisciplinary clinic dedicated to the care of patients with ACC.

Publisher

The Endocrine Society

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism

Link

http://academic.oup.com/edrv/article-pdf/35/2/282/8863951/edrv0282.pdf

Reference393 articles.

1. The clinically inapparent adrenal mass: update in diagnosis and management;Mansmann;Endocr Rev,2004

2. Higher-than-conventional radiation doses in localized prostate cancer treatment: a meta-analysis of randomized, controlled trials;Viani;Int J Radiat Oncol Biol Phys,2009

3. Clinical review: Adrenocortical carcinoma: clinical update;Allolio;J Clin Endocrinol Metab,2006

4. Extent of disease at presentation and outcome for adrenocortical carcinoma: have we made progress?;Kebebew;World J Surg,2006

5. Mortality rate of adrenocortical tumors in children under 15 years of age in Curitiba, Brazil;Pianovski;Pediatr Blood Cancer,2006

Cited by 710 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Powder Self-Emulsifying Drug Delivery System for Mitotane: In Vitro and In Vivo Evaluation;Pharmaceutics;2024-09-11

2. Treatment Outcomes in Patients with Recurrent Adrenocortical Carcinoma;Endocrine Research;2024-09-02

3. Analysis of miR-483-3p and miR-630 expression profile in pediatric adrenocortical tumors and the effect of their modulation on adrenal tumorigenesis in vitro.;Molecular and Cellular Endocrinology;2024-09

4. Dlk1 is a novel adrenocortical stem/progenitor cell marker that predicts malignancy in adrenocortical carcinoma;2024-08-22

5. The Effect of Adrenalectomy on Overall Survival in Metastatic Adrenocortical Carcinoma;The Journal of Clinical Endocrinology & Metabolism;2024-08-20